Department of Obstetrics and Gynaecology

Berlin, 20th April 2016 Statement on the planned Design of the G-BA for Changing of Directives on medical Measures for artificial Insemination (KB -RL) - Semen Analysis Parameter for an Indication for Intracytoplasmic Sperm Injection rather than In-vitro-Fertilization (2016) Wallwiener D, Beckmann M Journal article Does differential HLA-E and -F expression cause an aberrant immune tolerance in preeclampsia and HELLP? (2016) Würfel F, Hübner H, Strick R, Fasching P, Beckmann M, Wuerfel W, Rübner M Conference contribution Berlin, 15th July 2016 Report on the Outline of the "Guideline for Obtaining Blood and Blood Components and for the Usage of Blood Products (Guideline of Haemotherapy)" Report of the German Society of Gynaecology and Obstetrics (GSGO) (2016) Wallwiener D, Beckmann M Journal article Berlin, 20th June 2016 Report for Modification of the Guideline about the Early Detection of Diseases in Children under the Age of 6 Years (Children's Guideline): Screening for critical congenital Heart Disease using Pulse Oximetry in Newborn Report of the German Society of Gynaecology and Obstetrics (GSGO) (2016) Wallwiener D, Beckmann M Journal article Berlin, 29 July 2016 Opinion on the Preliminary Report of the IQTiG on the planning-relevant Quality Indicators (2016) Wallwiener D, Beckmann M Journal article Berlin, 2nd May 2016 Opinion on the Preliminary Report A10-03 (2016) Wallwiener D, Beckmann M, Schulz-Wendtland R Journal article The DETECT Study Concept - Metastatic breast cancer and circulating tumor cells (2016) Schramm A, Friedl T, Rack B, Trapp E, Fasching P, Taran FA, Hartkopf A, et al. Conference contribution Targeted Intraoperative Radiation Therapy Tumor Bed Boost During Breast-Conserving Surgery After Neoadjuvant Chemotherapy in TNBC and HER2 Positive Breast Cancer (2016) Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Liedtke C, et al. Conference contribution TREAT CTC: An innovative therapy approach to eliminate circulating tumor cells (CTCs) (2016) Tzschaschel M, Trapp E, Rack B, Messina C, Mueller V, Fehm T, Janni W, et al. Conference contribution Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial (2016) Janning M, Mueller , Vettorazzi E, Cubas-Cordova M, Gensch , Ben Batalla , Eulenburg ZC, et al. Conference contribution